参考文献/References:
[1] 汪志雄,杨思远. 经导管主动脉瓣置换术的现状及进展[J]. 中西医结合心脑血管病杂志,2021,19(22):3907-3911.
[2] Tanawuttiwat T,O’Neill B,and Cohen M. New-onset atrial fibrillation after aortic valve replacement comparison of transfemoral,transapical,transaortic,and surgical approaches[J]. J Am Coll Cardiol,2014,63(15):1510-1519.
[3] Zhou SC,Xu K,Wang B,et al. One-year follow-up results of atrial fibrillation patients who undergoing transcatheter aortic valve implantation[J]. Zhonghua Xin Xue Guan Bing Za Zhi,2022,50(2):132-136.
[4] Ammar A,Elbatran AI,Wijesuriya N,et al. Management of atrial fibrillation after transcatheter aortic valve replacement:challenges and therapeutic considerations[J]. Trends Cardiovasc Med,2021,31(6):361-367.
[5] Chao TF,Nedeljkovic MA,Lip GYH,et al. Stroke prevention in atrial fibrillation:comparison of recent international guidelines[J]. Eur Heart J Suppl,2020,22(Suppl O):O53-O60.
[6] 陈莎莎,周达新. 经导管主动脉瓣置换术后抗栓策略的研究进展[J]. 上海医药,2021,42(19):3-5.
[7] 张倩,王墨扬,吴永健. 《经导管主动脉瓣置换术中国专家共识（2020更新版）》解读[J]. 华西医学,2021,36(9):1191-1195.
[8] Vavuranakis M,Kalogeras K,Vrachatis D,et al. Antithrombotic therapy in patients undergoing TAVI with concurrent atrial fibrillation. One center experience[J]. J Thromb Thrombolysis,2015,40(2):193-197.
[9] Abdul-Jawad Altisent O,Durand E,Mu?oz-García AJ,et al. Warfarin and antiplatelet therapy versus?warfarin alone for treating patients?with?atrial fibrillation undergoing transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv,2016,9(16):1706-1717.
[10] Geis NA,Kiriakou C,Chorianopoulos E,et al. Feasibility and safety of vitamin K antagonist monotherapy in atrial fibrillation patients undergoing transcatheter aortic valve implantation[J]. EuroIntervention,2017,12(17):2058-2066.
[11] Geis NA,Kiriakou C,Chorianopoulos E,et al. NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation[J]. Clin Res Cardiol,2018,107(9):799-806.
[12] Butt JH,de Backer O,Olesen JB,et al. Vitamin K antagonists vs. direct oral anticoagulants after transcatheter aortic valve implantation in atrial fibrillation[J]. Eur Heart J Cardiovasc Pharmacother,2021,7(1):11-19.
[13] Ueyama H,Kuno T,Ando T,et al. Meta-analysis comparing direct oral anticoagulants versus vitamin k antagonists after transcatheter aortic valve implantation[J]. Am J Cardiol,2020,125(7):1102-1107.
[14] Seeger J,Gonska B,Rodewald C,et al. Apixaban in patients with atrial?fibrillation?after transfemoral aortic?valve?replacement[J]. JACC Cardiovasc Interv,2017,10(9):66-74.
[15] van Mieghem NM,Unverdorben M,Valgimigli M,et al. Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial[J]. Am Heart J,2018,205:63-69.
[16] Mangner N,Crusius L,Haussig S,et al. Continued versus interrupted oral anticoagulation during transfemoral transcatheter aortic valve implantation and impact of postoperative anticoagulant management on outcome in patients with atrial fibrillation[J]. Am J Cardiol,2019,123(7):1134-1141.
[17] Kawashima H,Watanabe Y,Hioki H,et al. Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after TAVR[J]. JACC Cardiovasc Interv,2020,13(22):2587-2597.
[18] Tarantini G,Mojoli M,Urena M. Atrial fibrillation in patients undergoing transcatheter aortic valve implantation:epidemiology,timing,predictors,and outcome[J]. Eur Heart J,2017,38(17):1285-1293.
[19] van Mieghem NM,Unverdorben M,Hengstenberg C,et al. Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR[J]. N Engl J Med,2021,385(23):2150-2160.
[20] Jochheim D,Barbanti M,Capretti G,et al. Oral anticoagulant type and outcomes?after transcatheter aortic?valve replacement[J]. JACC Cardiovasc Interv,2019,12(16):1566-1576.
[21] Carmeliet T,Vermeersch P,Prihadi EA. Late clinical valve thrombosis after transcatheter aortic valve replacement despite non-vitamin K anticoagulant[J]. JACC Case Rep,2021,3(10):1275-1280.
[22] Parashar A,Sud K,Devgun J,et al. Feasibility of LAA closure for left atrial thrombus in?patients with aortic stenosis and AF[J]. J Am Coll Cardiol,2016,68(7):770-771.
[23] 王宇彬,宋光远,张海彤,等. 经导管主动脉瓣置换术后心房颤动行左心耳封堵术二例[J]. 中国循环杂志,2019,34(2):196-197.
[24] 周道,戚鑫瑞,朱齐丰,等. 经导管主动脉瓣置换术后并发症的防治研究进展[J]. 内科急危重症杂志,2021,27(6):448-452.
[25] 左海润,徐承义,苏晞. “一站式”经导管主动脉瓣置换术联合左心耳封堵术的临床现状[J]. 中国介入心脏病学杂志,2021,29(12):708-711.
[26] 左海润,徐承义,苏晞,等. “一站式”经导管主动脉瓣置换术联合左心耳封堵术一例[J]. 华西医学,2021,36(9):1315-1317.
[27] 刘海涛,杨亚丽,朱存军,等. 经导管主动脉瓣置换加左心耳封堵术1例[J]. 心脏杂志,2021,33(4):464-466.
[28] Sinning JM,Hammerstingl C,Vasa-Nicotera M,et al. Transcatheter aortic valve implantation and closure of the left atrial appendage under cerebral protection[J]. EuroIntervention,2012,8(5):640-641.
[29] Khattab AA,Gloekler S,Sprecher B,et al. Feasibility and outcomes of combined transcatheter aortic valve replacement with other structural heart interventions in a single session:a matched cohort study[J]. Open Heart,2014,1(1):e000014.
[30] Fusari M. Clopidogrel,aspirin and proton pump inhibition after percutaneous valve implants:an update[J]. Curr Pharm Des,2013,19(22):3932-3945.
[31] Costa G, Goncalves L,Teixeira R. Antithrombotic therapy after transcatheter aortic valve implantation in patients with concomitant indications for long-term oral anticoagulation:a systemic review and meta-analysis[J]. Circulation,2020,142(suppl 3):A12786.
[32] Yokoyama Y,Briasoulis A,Takagi H,et al. Anticoagulation with or without antiplatelet therapy following transcatheter aortic valve replacement for patients with atrial fibrillation:a meta-analysis[J]. Cardiovasc Revasc Med,2021,24:42-47.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(8):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(8):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]王慧,饶莉.经导管主动脉瓣植入术的影像学研究进展[J].心血管病学进展,2015,(5):531.[doi:10.3969/j.issn.1004-3934.2015.05.002]
WANG Hui,RAO Li.Advances in Study of Imaging of Transcatheter Aortic Valve Implantation[J].Advances in Cardiovascular Diseases,2015,(8):531.[doi:10.3969/j.issn.1004-3934.2015.05.002]
[9]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(8):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[10]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(8):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]